MediThinQ, a South Korea-based innovator in surgical visualisation technologies, has entered into an exclusive multi-year distribution agreement with US-based Synovis Micro Companies Alliance, Inc. (Synovis MCA), a subsidiary of Baxter International Inc., to commercialise SHIYA, its 3D surgical visualisation platform.
The system combines a high-resolution digital exoscope with up to 20x magnification and its proprietary wearable display, SCOPEYE, allowing surgeons to operate without reliance on traditional eyepieces.
The agreement enables the global rollout of SHIYA through Synovis MCA, leveraging the company's deep-rooted expertise in microsurgery and its longstanding relationships with leading hospitals and world-renowned reconstructive surgeons.
With a presence across key international markets and a reputation built over more than three decades, Synovis MCA provides a highly specialised commercial and clinical platform to accelerate adoption of SHIYA worldwide.
Synovis MCA is uniquely positioned to support the continued evolution of microsurgery from conventional optical microscopes toward advanced digital visualisation systems.
To date, SHIYA has been used in more than 100 procedures globally, with findings supported by peer-reviewed research. By leveraging Synovis MCA's deep clinical expertise in microsurgery and its trusted relationships with leading surgeons, MediThinQ is well-positioned to accelerate adoption and ensure SHIYA meets the real-world needs of complex reconstructive procedures.
